Status:
UNKNOWN
New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Deutsche Klinik fuer Diagnostik
Conditions:
CIN
Cervical Cancer
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
It is to investigate to what extent a gentle tissue extraction of CIN lesions of the cervix will bring the same conclusion than the conventional cervix biopsy, but with less pain and morbidity, after ...
Eligibility Criteria
Inclusion
- Women between 18 and 80
- Karnofsky-Index of 80 and higher
- Cytological suspicious CIN and a colposcopical impression of a major lesion (therapeutical endpoint: conisation)
Exclusion
- Former malign disease oft he pelvic organs
- Pregnancy
- Serious internistic diseases
- Drug addiction
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01836588
Start Date
March 1 2013
End Date
April 1 2014
Last Update
April 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité
Berlin, Germany, 10117